GlaxoSmithKline PLC — Director's Dealing 2018

Jul 27, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0654W

GlaxoSmithKline PLC

27 July 2018

GlaxoSmithKline plc (the 'Company')

Transaction notification

The Company changed suppliers in respect of Long-Term Incentives administration in May 2018. On 26 July 2018, Ordinary Shares and American Depositary Shares (ADS) held by Executive Directors and Persons Discharging Managerial Responsibilities (PDMRs) in nominee accounts were transferred from the previous administrator to the new administrator.

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms E Walmsley
b)	Position/status	Chief Executive Officer
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Transfer of Ordinary Shares between accounts. No change in beneficial ownership.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
	£0.00	121,966.031
d)	Aggregated information	n/a (single transaction)
Aggregated volume Price
e)	Date of the transaction	2018-07-26
f)	Place of the transaction	Off market

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr R G Connor
b)	Position/status	President, Global Manufacturing & Supply
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Transfer of Ordinary Shares between accounts. No change in beneficial ownership.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
	£0.00	3,361.333
d)	Aggregated information	n/a (single transaction)
Aggregated volume Price
e)	Date of the transaction	2018-07-26
f)	Place of the transaction	Off market

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr L Debruyne
b)	Position/status	President, Global Vaccines
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Transfer of Ordinary Shares between accounts. No change in beneficial ownership.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
	£0.00	88,000.060
d)	Aggregated information	n/a (single transaction)
Aggregated volume Price
e)	Date of the transaction	2018-07-26
f)	Place of the transaction	Off market

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr S Dingemans
b)	Position/status	Chief Financial Officer
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Transfer of Ordinary Shares between accounts. No change in beneficial ownership.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
	£0.00	83,440.728
d)	Aggregated information	n/a (single transaction)
Aggregated volume Price
e)	Date of the transaction	2018-07-26
f)	Place of the transaction	Off market

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr N Hirons
b)	Position/status	SVP, Global Ethics & Compliance
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Transfer of Ordinary Shares between accounts. No change in beneficial ownership.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
	£0.00	24,588.491
d)	Aggregated information	n/a (single transaction)
Aggregated volume Price
e)	Date of the transaction	2018-07-26
f)	Place of the transaction	Off market

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr N Hirons
b)	Position/status	SVP, Global Ethics & Compliance
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature of the transaction	Transfer of ADSs between accounts. No change in beneficial ownership.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
	$0.00	1,528.812
d)	Aggregated information	n/a (single transaction)
Aggregated volume Price
e)	Date of the transaction	2018-07-26
f)	Place of the transaction	Off market

	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr B McNamara
b)	Position/status	CEO, GSK Consumer Healthcare
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature of the transaction	Transfer of ADSs between accounts. No change in beneficial ownership.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
	$0.00	36,712.903
d)	Aggregated information	n/a (single transaction)
Aggregated volume Price
e)	Date of the transaction	2018-07-26
f)	Place of the transaction	Off market

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr D S Redfern
b)	Position/status	Chief Strategy Officer
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Transfer of Ordinary Shares between accounts. No change in beneficial ownership.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
	£0.00	154,521.108
d)	Aggregated information	n/a (single transaction)
Aggregated volume Price
e)	Date of the transaction	2018-07-26
f)	Place of the transaction	Off market

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms C Thomas
b)	Position/status	SVP, Human Resources
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Transfer of Ordinary Shares between accounts. No change in beneficial ownership.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
	£0.00	97,974.175
d)	Aggregated information	n/a (single transaction)
Aggregated volume Price
e)	Date of the transaction	2018-07-26
f)	Place of the transaction	Off market

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mrs K Thomson
b)	Position/status	PCA of Mr P C Thomson (President, Global Affairs)
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Transfer of Ordinary Shares between accounts. No change in beneficial ownership.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
	£0.00	10,122.428
d)	Aggregated information	n/a (single transaction)
Aggregated volume Price
e)	Date of the transaction	2018-07-26
f)	Place of the transaction	Off market

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr P C Thomson
b)	Position/status	President, Global Affairs
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Transfer of Ordinary Shares between accounts. No change in beneficial ownership.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
	£0.00	16,702.991
d)	Aggregated information	n/a (single transaction)
Aggregated volume Price
e)	Date of the transaction	2018-07-26
f)	Place of the transaction	Off market

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr D E Troy
b)	Position/status	SVP & General Counsel
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature of the transaction	Transfer of ADSs between accounts. No change in beneficial ownership.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
	$0.00	184,542.810
d)	Aggregated information	n/a (single transaction)
Aggregated volume Price
e)	Date of the transaction	2018-07-26
f)	Place of the transaction	Off market

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHEDLFLVDFLBBX